CLINICAL_TRIALS
ClinicalTrials.gov record update
Pilot Study to Evaluate the Signaling Pathway Modulation Demonstrated by Raf, MEK, and Kinase Inhibitors In Human Skin With or Without Solar Simulated Light
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT03176485
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:37:03.254122+00:00
- Published At
- 2019-01-04T00:00:00+00:00
- Record Updated At
- 2019-01-04
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Metastatic Cancer", "Melanoma", "Colon Cancer", "Differentiated Thyroid Cancer", "Hepatocellular Carcinoma", "Renal Cell Carcinoma", "Metastatic Melanoma", "HCC", "Metastatic Colon Cancer"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2019-01-04"- protocolSection.identificationModule.nctId
"NCT03176485"- protocolSection.identificationModule.officialTitle
"Pilot Study to Evaluate the Signaling Pathway Modulation Demonstrated by Raf, MEK, and Kinase Inhibitors In Human Skin With or Without Solar Simulated Light"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["NA"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.